PharmaShots | Incisive News in 3 Shots

Subscribe Now

Amgens

The US FDA Accepts Amgen's BLA for Tarlatamab and Granted Priority Review for Advanced Small Cell Lung Cancer

The US FDA Accepts Amgen's BLA for Tarlatamab and Granted Priority Review for Advanced Small Cell Lung Cancer

December 14, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us